?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
Resource type:
Biosimilars Educational Resources
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
September 26, 2022
signalgroup
Biosimilars: Non-Medical Switching and Transitioning
September 15, 2021
signalgroup
Separate Codes and Payment for Biosimilars
June 14, 2021
signalgroup
Biosimilars Have Significantly Lowered Prices of All Biologics
October 3, 2019
signalgroup
FDA Patient Materials
July 3, 2019
Katie Quinn
Biosimilars FAQs
July 3, 2019
Katie Quinn
Biosimilars Overview
July 3, 2019
Katie Quinn
Analysis Shows Biosimilars Lower Patient Costs
March 19, 2019
Katie Quinn
Structural Market Changes Needed to Achieve Cost-Savings from Biosimilars
October 3, 2018
Katie Quinn
Science-Based Resource on the Basic Facts About Biosimilars